We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01730534
Recruitment Status : Active, not recruiting
First Posted : November 21, 2012
Last Update Posted : December 28, 2017
Bristol-Myers Squibb
The TIMI Study Group
Hadassah Medical Organization
Information provided by (Responsible Party):